Monday, March 17, 2025 | 08:15 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Panel clears Covid-19 vaccine manufactured by Serum Institute: Reports

The Serum Institute of India (SII), the local maker of the vaccine called Covishield, has stockpiled about 50 million doses of the vaccine, enough for 25 million people, said its CEO last week

Sinovac, Vaccine
Premium

The decision on Covishield potentially paves the way for the vaccine’s rollout in the world’s second-most populous country

BS Web Team New Delhi
A panel comprising experts appointed by the government on Friday approved a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use in India, said media reports.
 
The Serum Institute of India (SII), the local maker of the vaccine called Covishield, has stockpiled about 50 million doses of the vaccine, enough for 25 million people, said its CEO last week. The committee listed certain conditions for the vaccine while giving its approval, LiveMint reported. A formal clearance from V G Somani, Drugs Controller General of India (DCGI), is likely to follow soon. There is no clarity on the committee’s

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in